Startup Pinnacle Medicines is growing peptide medication with the identical efficacy as biologic medicines and the dosing comfort of oral small molecules. The lead program of OrbiMed-incubated Pinnacle is on monitor to enter the clinic in bronchial asthma and continual obstructive pulmonary illness.
The publish Pinnacle Medicines Provides $89M for Oral Peptides With Properties of Injectable Biologics appeared first on MedCity Information.
